ACIU
AC Immune Ltd
NASDAQ: ACIU · HEALTHCARE · BIOTECHNOLOGY
$2.97
-1.33% today
Updated 2026-05-06
Market cap
$303.29M
P/E ratio
—
P/S ratio
84.88x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $4
Volume
0.3M
AC Immune Ltd (ACIU) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-4,262.00%
ROE
-89.60%
ROA
-22.40%
Debt/equity
0.07x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $8.64M | $-11.24M | -98.91% | -133.12% | -130.17% |
| 2014 | $30.27M | $10.74M | 46.76% | 35.41% | 35.50% |
| 2015 | $39.09M | $20.27M | 56.39% | 47.64% | 51.85% |
| 2016 | $23.21M | $-7.10M | -11.03% | -45.04% | -30.57% |
| 2017 | $20.25M | $-26.41M | -61.26% | -111.28% | -130.39% |
| 2018 | $7.19M | $-50.95M | -515.47% | -688.77% | -708.24% |
| 2019 | $110.46M | $45.44M | 54.34% | 40.32% | 41.14% |
| 2020 | $15.43M | $-61.92M | -285.50% | -396.99% | -401.28% |
| 2021 | $944000.00 | $-73.00M | -6,597.67% | -8,369.70% | -7,732.63% |
| 2022 | $3.94M | $-70.75M | 100.00% | -1,800.43% | -1,798.04% |
| 2023 | $14.80M | $-54.23M | -268.93% | -362.30% | -366.41% |
| 2024 | $27.31M | $-50.92M | -129.12% | -191.80% | -186.44% |
| 2025 | $3.57M | $-70.45M | 100.00% | -1,927.32% | -1,971.65% |